INCB007839
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INCB007839, covering 2012-01-25 to 2012-01-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer [Phase 1, Phase 2]